نتایج جستجو برای: b and t lymphocyte attenuator

تعداد نتایج: 17065848  

Journal: :Frontiers in Immunology 2021

The functions of bone marrow plasma cells (BMPC) beyond antibody production are not fully elucidated and distinct subsets BMPC suggest potential different functions. Phenotypic differences were identified for human depending on CD19 expression. Since is a co-stimulatory molecule the B-cell-receptor (BCR), IgA + IgM express BCR their surface, we here studied whether expression affects cellular r...

2017
Eisuke Domae Yuya Hirai Takashi Ikeo Seiji Goda Yoji Shimizu

Vγ9Vδ2 T cells, the major subset of the human peripheral blood γδ T-cell, respond to microbial infection and stressed cells through the recognition of phosphoantigens. In contrast to the growing knowledge of antigen-mediated activation mechanisms, the antigen-independent and cytokine-mediated activation mechanisms of Vγ9Vδ2 T cells are poorly understood. Here, we show that interleukin (IL) -12 ...

Journal: :Biocell 2023

B and T-lymphocyte attenuator (BTLA) plays an immunosuppressive role by inhibiting T- B-cell functions. BTLA is associated with a variety of diseases, especially cancer immunity. However, the function in various cancers its clinical prognostic value have still not been comprehensively analyzed. This study aimed to identify relationship between from perspectives differences expression, value, im...

Journal: :Cell 2016
Michael Boice Darin Salloum Frederic Mourcin Viraj Sanghvi Rada Amin Elisa Oricchio Man Jiang Anja Mottok Nicolas Denis-Lagache Giovanni Ciriello Wayne Tam Julie Teruya-Feldstein Elisa de Stanchina Wing C. Chan Sami N. Malek Daisuke Ennishi Renier J. Brentjens Randy D. Gascoyne Michel Cogné Karin Tarte Hans-Guido Wendel

The HVEM (TNFRSF14) receptor gene is among the most frequently mutated genes in germinal center lymphomas. We report that loss of HVEM leads to cell-autonomous activation of B cell proliferation and drives the development of GC lymphomas in vivo. HVEM-deficient lymphoma B cells also induce a tumor-supportive microenvironment marked by exacerbated lymphoid stroma activation and increased recruit...

Journal: :International Journal of Cancer 2021

Therapy with immune checkpoint inhibitors (ICIs) can lead to durable tumor control in patients various advanced stage malignancies. However, this is not the case for all patients, leading an ongoing search biomarkers predicting response and outcome ICI. The B T lymphocyte attenuator (BTLA) expressed on cells that was shown modulate therapeutic responses. Here, we evaluate circulating levels of ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید